7-oxo-7-(4-n-propoxyphenyl)heptanoic acid, 97.0%, 2g

N,N-Diethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine, 95.0%, 1g

2'-Cyano-2,2,2-trifluoroacetophenone monohydrate, 97.0%, 1g

(R)-3-Methoxypyrrolidine hydrochloride, 95.0%, 10g

1-(Tetrahydrofuran-3-yl)-1H-imidazol-2-amine, 1g

(S)-N-[(2-Fluorophenyl)methyl]piperidin-3-amine dihydrochloride, 95.0%, 1g

N,N-Diisopropylethylamine (DIPEA), 100mL, >=99.5%, for peptide synthesis, glass packaging

8-Bromo-3-methylimidazo[1,2-a]pyridine-2-carboxylic acid, 250mg

Acid-PEG4-S-S-PEG4-acid, 250mg

4,4,5,5-Tetramethyl-2-(2,4,5-trimethylphenyl)-1,3,2-dioxaborolane, 97%, 100mg

5-(Ethoxycarbonyl)furan-2-carboxylic acid, 95+%, 250mg

2-Formyl-1H-indole-6-carbonitrile, 95.0%, 1g

(S)-2-Amino-4-phenylbutanoic acid hydrochloride, 95.0%, 1g